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Abstract 
Neoadjuvant radio chemotherapy and immediate reconstruction for breast cancer are still under debate. But there 
are recent abstracts and articles which show that neoadjuvant radio chemotherapy is feasible and could improve the 
clinical outcome of breast cancer patients. The aim of this review is to present the authors’ techniques and approaches 
with regard to neoadjuvant radiation of breast cancer patients. It seems that the concept of Immediate implant 
DElayed AutoLogous breast reconstruction could be a safe procedure that is at least equivalent to primary autologous 
reconstruction.
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Background
Neoadjuvant radio chemotherapy in breast cancer is 
still under debate. The concern of surgeons is that com-
bined radio chemotherapy will affect the cosmetic results 
of their procedure and will cause severe side effects like 
impaired wound healing or fat necrosis. However, recent 
studies with long-term results, especially from the Uni-
versity of Dusseldorf, have shown that neoadjuvant radio 
chemotherapy is feasible and can improve the clinical 
outcome of breast cancer patients. This is in accordance 
with treatment modalities in other tumour entities like 
neoadjuvant radio chemotherapy for rectal or oesopha-
gus cancer. Here, radio chemotherapy could demonstrate 
that the clinical outcome was not affected. In this review, 
we examine the actual status of neoadjuvant radio chem-
otherapy for breast cancer and investigate what kind of 
surgical procedures is available and the authors personal 
technique of the IDEAL concept (immediate implant 
delayed autologous) for immediate breast reconstruction 
is presented.
Review
The review was achieved by performing a pubmed and 
medline research using the search term neoadjuvant 
radio chemotherapy, breast cancer, cosmetic results and 
acute/late side effects, immediate breast reconstruction, 
breast implant, autologous breast reconstruction, DIEP 
flap, TRAM flap, and IDEAL breast reconstruction.
Neoadjuvant radio chemotherapy is a very interesting 
approach for breast cancer patients. It helps to reduce the 
tumour burden. Furthermore, there is an option to evalu-
ate if the applied chemotherapy leads to a tumour reduc-
tion. Complete pathological response would be the best 
clinical result. This approach is in accordance with other 
tumour entities. In rectal cancer for T3 N+, neoadju-
vant radio chemotherapy is the gold standard. With this 
procedure, the local relapse rate could be significantly 
reduced. With this approach and the mesorectal incision, 
the recurrence rate could be reduced below 10 %.
During 1991–1998, a total of 315 LABC (locally 
advanced breast cancer), patients (cT1-cT4/cN0-N1) 
were treated with neoadjuvant radio chemotherapy at the 
University of Dusseldorf. Preoperative radiotherapy (RT) 
consisted of external beam radiation therapy (EBRT) of 
50 Gy (5 × 2 Gy/week) to the breast and the supra-/infra-
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in 214 cases afterwards or—in case of breast conserva-
tion—a 10 Gy interstitial boost with (192) Ir after loading 
before EBRT. Chemotherapy was administered prior to 
RT in 192 patients and concomitantly in 113; 10 patients 
received no chemotherapy.
In 64 patients after breast conserving surgery and in 32 
patients after mastectomy, a long-term follow-up of the 
cosmetic results was possible. Most patients rated their 
cosmetic results as excellent or good (80  % breast con-
serving surgery and 56 % mastectomy). After a follow-up 
of 14–21 years, we did not detect any grade III–IV fibro-
sis (24).
Skin-sparing mastectomy with immediate breast 
reconstruction (SSM-IBR) is increasingly used in inva-
sive breast cancer. However, adjuvant chemotherapy 
(CT) and radiotherapy (RT) can increase the rate of local 
complications. Cécile Zinzindohoué et al. [24] published 
in 2016 a French prospective study in Annals of Surgical 
Oncology, which assessed the morbidity of SSM-IBR with 
latissimus and implant after neoadjuvant chemotherapy 
and radiotherapy. Among 94 patients included in this 
study, 83 were analysed (mean age 45.2 ±  9.5 years, T1 
23.6 %, T2 55.6 %, T3 18.1 %). All but one patient received 
anthracyclines and taxanes and all patients received RT 
(49.3 ±  5.2  Gy) before SSM–IBR. Prostheses were used 
for IBR in 32 patients (mean volume 256 ± 73 mm3). Five 
patients had necrosis (≤2 cm, 2.2–10 cm2 and >10 cm2, 
in three, one and one cases, respectively) and they all 
recovered without revision surgery. Among 50 patients 
who underwent upfront mastectomy, 36 % achieved pCR. 
Like our results in this trial, neoadjuvant radio chemo-
therapy was safe, with an acceptable local morbidity rate.
The technique of nipple sparing mastectomy with 
immediate reconstruction is an oncologically safe proce-
dure [14, 19, 23, 24] and associated with the best aesthetic 
results [7, 19] in case of therapeutic as well as of pro-
phylactic mastectomies and if the postoperative course 
is uneventful. Autologous reconstruction by DIEP- or 
TRAM flap is associated with superior long time results 
[19, 6], but there are several surgery-associated compli-
cations which can severely impair long time results and 
oncologic outcome.
If a therapeutic mastectomy is planned as the primary 
cancer surgery simultaneously with a sentinel node 
biopsy, the tumour stage could be upgraded and the 
oncologic therapy regimen may switch to chemotherapy 
and post-mastectomy radiation even in cases that ini-
tially presented as in  situ cancer by core needle biopsy. 
After complex oncologic and reconstructive surgery, a 
delay in adjuvant systemic therapy or radiation therapy 
cannot be excluded at least in single patients. But also 
in larger series and matched pair analysis, a significant 
delay of oncologic therapies was shown in patients with 
complications [2–4, 9, 12, 16, 22]. For immediate autolo-
gous reconstruction, the need for postmastectomy radia-
tion after DIEP-or TRAM-flap surgery has the potential 
to deteriorate the aesthetic result, resulting in a fat fibro-
sis of the transferred tissue.
A further basic oncologic problem are positive resec-
tion margins in nipple sparing mastectomy specimen, 
especially in case of multicentric or extensive locally dis-
ease which are the most frequent indications for thera-
peutic mastectomy. In case of insufficient localization of 
the non-tumour-free margins, this can result in the need 
for post-mastectomy or post-reconstruction radiation, 
secondary modified radical mastectomy or acceptance 
of a significantly higher recurrence risk. Even if re-resec-
tion can be planned in case of clear assignment, it still 
will impair shape, scarring and overall appearance of the 
reconstructed breast. In case of R1 resection of the retro 
areolar region, the secondary excision of the nipple areo-
lar complex (NAC) can be only compensated in autolo-
gous immediate reconstruction, if the flap was buried 
with the skin island and de-epithelialized in a second step 
after final histology.
Finally, the NSM technique is a highly demanding pro-
cedure in respect of skin and NAC perfusion, so that 
there will be a percentage between 2 and 22 % of skin or 
nipple necrosis. The rate of perfusion complications var-
ies by surgical skills, mastectomy incision type [11, 16] 
and patients risk factors such as local factors like ptosis 
or breast hyperplasia with a need for mastopexy tech-
niques. On the other hand, systemic factors like smoking, 
diabetes or obesity contribute to local complications. The 
combination of immediate autologous reconstruction 
and skin or NAC necrosis will end up in inferior aesthetic 
long-term results.
Currently, there are several published techniques to 
overcome problems associated with NSM/SSM and 
immediate reconstruction. The combination of implant 
surgery and the need of post-mastectomy radiation lead 
to higher rates of capsular contraction, reoperations, 
wound healing problems and implant loss [15, 17, 20, 21] 
and complication rates are slightly higher when radiation 
was before immediate reconstruction. In contrary in cases 
of complications of a complex reconstructive surgery 
before chemotherapy or radiation, there will be a higher 
probability of a delay of adjuvant oncologic therapies [5].
In case of indicated post-mastectomy radiation after 
immediate autologous reconstruction, the higher rate of 
volume loss, and fat necrosis due to tissue fibrosis [10, 
13, 18] will lead to inferior results. With respect to recent 
publications [5], current guidelines [1], therefore, recom-
mend autologous reconstruction to be performed after 
radiation therapy to avoid negative radiation effects on 
the healthy flap tissue.
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On the other hand, implant reconstruction is recom-
mended to be performed before radiotherapy to avoid 
wound healing problems of radiated tissue. For the 
majority of patients, it is impossible to decide as early as 
at the time of breast cancer diagnosis for either a defi-
nite heterologous or autologous reconstructive proce-
dure: Furthermore, because in the standard oncologic 
approach for breast cancer surgery the result of the sen-
tinel node biopsy is not clear, the planning of a primary 
reconstructive concept is difficult.
To avoid the coincidence of possible local oncologic 
or surgical ischaemic problems of NSM in the setting 
of autologous immediate reconstruction which could 
destroy the otherwise perfect long-term results of a 
highly specialized often microsurgical flap surgery, we 
decided to switch to an algorithm that is planned with 
an NSM and immediate breast reconstruction with 
implants only as the immediate implant delayed autolo-
gous concept (IDEAL concept). No immediate autolo-
gous reconstruction is done in the case of NSM, but the 
patient is fully informed of all options of implant based 
or autologous reconstructive procedures before abla-
tive surgery. In case of uncertainty of the patients desire 
for autologous reconstruction or in case of confirmed 
patients desire for implant-based breast reconstruction, 
we offer a direct to implant reconstruction with mesh/
matrix support (DTIMS) where the implant is placed 
partially subpectorally. If the patient opted for an autol-
ogous reconstruction, which is done mainly by uni- or 
bilateral DIEP flap procedure, she is counselled by the 
microsurgeon before the nipple sparing mastectomy and 
the implant is placed epipectorally at the end of the NSM 
procedure. Both surgical procedures of NSM with epi- or 
subpectoral implant positioning are performed by the 
specialized breast surgeon of the senology team.
The personal technique of therapeutic or prophylactic 
nipple sparing mastectomy is combined with a simulta-
neous adjustment of the skin envelope whenever nec-
essary in case of breast hyperplasia or ptosis, but in the 
majority of moderate skin excess the spontaneous breast 
skin retraction over the underlying implant is awaited. In 
case of therapeutic mastectomy intraoperatively, pretu-
moural re-resections are taken and in all cases of thera-
peutic or prophylactic mastectomy ventral re-resections 
are taken quadrant wise and from the retro areolar area. 
No frozen section was done but only the complete his-
tologic report was seen as indication for resection of the 
NAC. The desired breast size can also result in reduction 
of large sized breasts as well as in a moderate augmenta-
tion (Fig. 1) and correction of other breast deformities as 
tubular breast. Mastectomy incisions are chosen when-
ever possible inferolaterally (Fig.  2a–h) and if necessary 
a superficial periareolar NAC re-centralization is added 
at the end of the surgery after the implant is in place. If 
the skin retraction is sufficient at the end of surgery, any 
additional lifting procedure is abandoned (Fig.  3). In 
cases of large breasts, an inverted T incision is planned 
for NSM with a craniocaudally NAC pedicle (Fig. 1).  
If the patient has chosen an autologous reconstruction 
as her definite reconstructive procedure, the immedi-
ate implant reconstruction was done epipectorally, after 
reconstruction of the lateral breast contour by Rayen 
stitches. A drain was put in place and the optimal implant 
shape and size were chosen by mastectomy weight, diam-
eter of breast base and filling of the skin envelope. A light 
circular bandage is placed in the operating room and 
changed to a bra without strong compression, which was 
worn for 6–8 weeks postoperatively. Drainages were kept 
until 20 ml per 24 h fluid production is seen. Prophylactic 
antibiotics were given as long as drainages were in place.
An uni- or bilateral DIEP flap or other autologous tis-
sue transfer was done after complete wound healing, in 
the presence of oncological clear resection margins and 
a safe mastectomy skin and NAC perfusion 4–6 months 
Fig. 1 a–b Bilateral NSM with epipectoral implant positioning after 
oncoplastic breast conserving therapy and radiation therapy on the 
right side with consecutive breast deformity and significant asymme‑
try (a). A correction of the skin envelope was done by augmentation 
on the right side and inverted T skin reduction on the left side (b)
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later (Table 1). This microsurgical procedure was done by 
the plastic surgeon who is especially trained in microsur-
gery in a high-throughput department on a daily basis. 
Fig. 2 a–h: Patient with IBC on the left side and a BRCA mutation (a–
b). After neoadjuvant chemotherapy, a bilateral NSM with correction 
of her tuberous breasts inframammary fold was planned (c–d) and 
an epipectoral implant reconstruction was performed (e–f). Implants 
were explanted and a DIEP flap was planned after 6 months (g–h)
Fig. 3 a–b: Result after bilateral NSM and epipectoral implant 
positioning (b) before planned DIEP flap. Note that the preoperatively 
planned periareolar NAC recentralization (a) was not done because of 
sufficient skin retraction at the end of the surgery
Table 1 Algorithm of IDEAL technique: immediate implant delayed 
autologous reconstruction
Indication for NSM and immediate reconstruction
Tumorectomy and / or SNE done
no indication for
CTx and RTx











Implant removal + flap surgery




NSM nipple sparing mastecomy; SNE sentinel node excision; CTx chemotherapy; 
RTx radiotherapy; PMRT post‑mastectomy radiotherapy; DTI direct to implant; 
DTIMS direct to implant with mesh/matrix support; CF capsular fibrosis
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Pedicle flap surgery was performed by the specialized 
breast surgeon of the senology department.
If a patient decided for a definite implant reconstruc-
tion with mesh support and the long-term follow up is 
unsatisfying for the patient, the procedure and switch 
to a DIEP flap can be done in the same way. Implant and 
capsule/mesh were removed, the pectoralis muscle is 
sutured back to the thoracic wall and the DIEP flap was 
placed epipectorally in the former implant pocket.
If the resection margins are not free of tumour at any area 
after the nipple sparing mastectomy specimen was exam-
ined by the pathologist, a localized re-resection was planned 
around 4–6 weeks postoperatively in any case, where tumour 
free margins could be achieved with a high probability. In 
cases of non-tumour-free margins in the retroareolar region, 
the NAC is resected and according to the amount of skin 
removed, the implant is changed to a tissue expander (TE).
The same manoeuver was done in cases of skin or NAC 
ischaemia and failure of conservative treatment [8]. After 
waiting some weeks for demarcation of necrosis, the 
region was excised and the implant was replaced by TE.
Due to the fact that oncologic therapies could be signifi-
cantly delayed by complications of complex reconstructive 
surgery [3, 4, 9, 22], we examine the nodal status by either 
sentinel lymph node excision or axillary dissection when-
ever indicated. The consequences for any indication for 
chemotherapy or post-mastectomy radiation are then con-
firmed or excluded and all oncologic adjuvant therapies are 
planned in a neoadjuvant setting before NSM and immedi-
ate implant reconstruction. The surgery is planned as early 
as 6–8 weeks after the end of the radiation therapy (Table 1).
Conclusion
It seems that neoadjuvant radio chemotherapy is a safe 
and reliable method in breast cancer patients. One inter-
esting approach is the concept of immediate implant, 
delayed autologous breast reconstruction in all cases of 
nipple sparing mastectomy to receive optimal oncologic 
therapy sequence as well as optimal aesthetic results.
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